Clinical Trial

Dominantly Inherited Alzheimer Network (DIAN)

Study Description

Dominantly Inherited Alzheimer Network (DIAN)

The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.

Additional Information

Official Study Title

Dominantly Inherited Alzheimer Network (DIAN)

Clinical Trial ID

NCT00869817

ParticipAid ID

9avgmb